BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 8082084)

  • 1. Gain of 1q is associated with inferior event-free and overall survival in patients with favorable histology Wilms tumor: a report from the Children's Oncology Group.
    Gratias EJ; Jennings LJ; Anderson JR; Dome JS; Grundy P; Perlman EJ
    Cancer; 2013 Nov; 119(21):3887-94. PubMed ID: 23983061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term outcomes for infants with very low risk Wilms tumor treated with surgery alone in National Wilms Tumor Study-5.
    Shamberger RC; Anderson JR; Breslow NE; Perlman EJ; Beckwith JB; Ritchey ML; Haase GM; Donaldson M; Grundy PE; Weetman R; Coppes MJ; Malogolowkin M; Shearer PD; Kletzel M; Thomas PR; Macklis R; Huff V; Weeks DA; Green DM
    Ann Surg; 2010 Mar; 251(3):555-8. PubMed ID: 20142733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current and emerging chemotherapy treatment strategies for Wilms tumor in North America.
    Gratias EJ; Dome JS
    Paediatr Drugs; 2008; 10(2):115-24. PubMed ID: 18345721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relapse-associated variables in stage I favorable histology Wilms' tumor. A report of the National Wilms' Tumor Study.
    Weeks DA; Beckwith JB; Luckey DW
    Cancer; 1987 Sep; 60(6):1204-12. PubMed ID: 3040208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal duration of preoperative therapy in unilateral and nonmetastatic Wilms' tumor in children older than 6 months: results of the Ninth International Society of Pediatric Oncology Wilms' Tumor Trial and Study.
    Tournade MF; Com-Nougué C; de Kraker J; Ludwig R; Rey A; Burgers JM; Sandstedt B; Godzinski J; Carli M; Potter R; Zucker JM;
    J Clin Oncol; 2001 Jan; 19(2):488-500. PubMed ID: 11208843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wilms' tumor in the neonate: a report from the National Wilms' Tumor Study.
    Hrabovsky EE; Othersen HB; deLorimier A; Kelalis P; Beckwith JB; Takashima J
    J Pediatr Surg; 1986 May; 21(5):385-7. PubMed ID: 3012057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Older age is an adverse prognostic factor in stage I, favorable histology Wilms' tumor treated with vincristine monochemotherapy: a study by the United Kingdom Children's Cancer Study Group, Wilm's Tumor Working Group.
    Pritchard-Jones K; Kelsey A; Vujanic G; Imeson J; Hutton C; Mitchell C; ;
    J Clin Oncol; 2003 Sep; 21(17):3269-75. PubMed ID: 12947062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison between single-dose and divided-dose administration of dactinomycin and doxorubicin for patients with Wilms' tumor: a report from the National Wilms' Tumor Study Group.
    Green DM; Breslow NE; Beckwith JB; Finklestein JZ; Grundy PE; Thomas PR; Kim T; Shochat SJ; Haase GM; Ritchey ML; Kelalis PP; D'Angio GJ
    J Clin Oncol; 1998 Jan; 16(1):237-45. PubMed ID: 9440748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between microsubstaging variables, age at diagnosis, and tumor weight of children with stage I/favorable histology Wilms' tumor. A report from the National Wilms' Tumor study.
    Green DM; Beckwith JB; Weeks DA; Moksness J; Breslow NE; D'Angio GJ
    Cancer; 1994 Sep; 74(6):1817-20. PubMed ID: 8082084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of Wilms' tumour. Current recommendations.
    Mehta MP; Bastin KT; Wiersma SR
    Drugs; 1991 Nov; 42(5):766-80. PubMed ID: 1723373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adult Wilms' tumor. Report of two cases and review of the literature.
    Hentrich MU; Meister P; Brack NG; Lutz LL; Hartenstein RC
    Cancer; 1995 Jan; 75(2):545-51. PubMed ID: 7812923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Teratoid Wilms' tumor: a case report with literature review.
    Inoue M; Uchida K; Kohei O; Nashida Y; Deguchi T; Komada Y; Kusunoki M
    J Pediatr Surg; 2006 Oct; 41(10):1759-63. PubMed ID: 17011284
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.